Literature DB >> 8157097

Neuronal pathways to the rat conjunctiva revealed by retrograde tracing and immunocytochemistry.

T Elsås1, L Edvinsson, F Sundler, R Uddman.   

Abstract

The origin and neuropeptide content of nerve fibres in the rat conjunctiva were studied by retrograde tracing and denervations in combination with immunocytochemistry. Immunocytochemistry revealed nerve fibres containing neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI), helospectin, substance P (SP), and calcitonin gene-related peptide (CGRP) around blood vessels, smooth muscle bundles and glands. Removal of the sphenopalatine ganglion eliminated the majority of the VIP-, PHI- and helospectin-containing fibres. Sympathectomy eliminated the majority of the NPY-containing fibres in the conjunctiva. Removal of both the sphenopalatine ganglion and the superior cervical ganglion led to further reduction of the NPY fibres. Injection of the retrograde tracer True Blue into the conjunctiva resulted in the appearance of labelled cell bodies in the trigeminal ganglion, the sphenopalatine ganglion, the superior cervical ganglion, and the ciliary ganglion. Judging from the number of labelled nerve cell bodies, the superior cervical ganglion contributes most to the innervation. These results indicate that the majority of NPY-containing nerve fibres in the conjunctiva derives from the superior cervical ganglion (sympathetic nerve supply). Most of the VIP- and a minor population of the NPY-containing fibres in the conjunctiva originate in the sphenopalatine ganglion (parasympathetic nerve supply). A sparse amount of VIP- and NPY-containing fibres derives from the ciliary ganglion. Nerve fibres containing SP and/or CGRP emanate from the trigeminal ganglia (sensory nerve supply). Together the findings indicate that several ganglia project to the conjunctiva and that many neuropeptides may be involved in the control of conjunctival activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157097     DOI: 10.1006/exer.1994.1201

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis).

Authors:  W Kirch; M Horneber; E R Tamm
Journal:  Anat Embryol (Berl)       Date:  1996-04

2.  Substance P and opioid peptidergic innervation of the anterior eye segment of the rat: an immunohistochemical study.

Authors:  J Michael Selbach; Samia H Buschnack; Klaus-Peter Steuhl; Stephan Kremmer; Uta Muth-Selbach
Journal:  J Anat       Date:  2005-03       Impact factor: 2.610

Review 3.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 4.  Autonomic control of the eye.

Authors:  David H McDougal; Paul D Gamlin
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

5.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

6.  Expression of immediate early genes in sensory ganglia.

Authors:  D A Groneberg; S Wiegand; Q T Dinh; C Peiser; J Springer; A Fischer
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

7.  Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea-pig conjunctiva.

Authors:  M Figini; P Javdan; F Cioncolini; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Neuroanatomy and neurochemistry of rat cornea: Changes with age.

Authors:  Jiucheng He; Thang Luong Pham; Haydee E P Bazan
Journal:  Ocul Surf       Date:  2020-12-17       Impact factor: 5.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.